In a speech on Monday at the John F. Kennedy library in Boston, President Joe Biden will outline new initiatives to build on his administration's "Cancer Moonshot" campaign to reduce deaths from the illness.
In his remarks, which coincide with the 60th anniversary of Kennedy's speech outlining his intention to send a man to the moon, Biden will make the announcement that he has chosen Renee Wegrzyn, an experienced science adviser, to serve as the first director of the Advanced Research Projects Agency for Health, which he established in March.
White House Says Biden Will Sign New Executive Order
The organization's goal is to increase the federal government's capacity to support biomedical and health research. The White House announced that Biden will also sign an executive order to promote biotechnology and biomanufacturing in order to guarantee that cutting-edge technologies, such as those required to fight cancer, will be developed and produced in the US.
Per NBC News, the president is also anticipated to highlight accomplishments made by the "Cancer Cabinet" advisory group, which he established earlier this year. These initiatives include those to close the screening gap, address environmental exposure, lessen the impact of cancers that are preventable, and provide patients and communities with the most recent research.
For instance, the cabinet is announcing that the climate and health care legislation Biden signed last month will lower the price of prescription drugs for cancer patients. Biden has made an effort to keep the momentum for funding public health research going. He has supported the Advanced Research Projects Agency for Health, which is structured after comparable R&D programs that aid the Pentagon and the intelligence community.
'Cancer Moonshot' Coordinator Emphasizes Importance of The Objective
ARPA-mandate H's is to research possible therapies and cures for diseases including diabetes, Alzheimer's, and cancer. A new National Cancer Institute scholar program that will support young researchers working on cancer treatments and cures will also be announced by him, CBS News reported.
It is still far too early to say whether these new blood tests for detecting cancer in healthy individuals will have any impact on the number of cancer deaths, according to experts. No studies have been done to demonstrate that they lower the chance of dying from cancer. But they still emphasize the significance of having a lofty objective.
Danielle Carnival, the White House cancer moonshot coordinator, stated that the longer-term study, which is anticipated to last up to a decade, was designed so that any promising diagnostic results could be quickly implemented into widespread practice. The objective, according to her, was to get closer to a time when cancers could be discovered through routine blood tests, potentially taking the place of more invasive and demanding procedures like colonoscopies and saving lives in the process.
Scientists now understand that cancer is not a single disease, but hundreds of diseases that respond differently to different treatments. Existing medications can target certain cancers' biomarkers to stop tumor growth. Many more targets await discovery.
According to The Hill, Biden will also mention the launch of National Cancer Institute study established to identify blood tests that can detect cancers to detect the illness in patients at an early stage.
Biden will also remark on investments in the bipartisan infrastructure legislation before the speech in Monday in Boston. The 46th US President, whose son, Beau, died of brain cancer at the age of 46 in 2015 is one of Biden's personal reason of being eager to end cancer. Throughout his campaign and presidency, Biden has talked about aiming to end cancer saying it would be his priority when he takes the office.
Related Article : Officials Blame President Joe Biden Over Southern Border Crisis After 9 Migrants Died Trying To Cross Rio Grande To Gain Access in US
